A kinome-wide CRISPR screen identifies CK1α as a novel target to overcome enzalutamide resistance of prostate cancer
Jinghui Liu(Inner Mongolia Agricultural University), Xiaoqi Liu(Indiana University Health)
Cited by 0
Related Papers
Copper-Catalyzed/Promoted Cross-coupling of <i>gem</i>-Diborylalkanes with Nonactivated Primary Alkyl Halides: An Alternative Route to Alkylboronic Esters
|Organic Letters|2014|161
Inhibition of the Wnt/β-Catenin Pathway Overcomes Resistance to Enzalutamide in Castration-Resistant Prostate Cancer
|Cancer Research|2018|154
p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer
|Oncogene|2020|114
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC)
|Journal of Biological Chemistry|2018|103
Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer
|Journal of Biological Chemistry|2019|83